Trubion Pharmaceuticals is a biopharmaceutical company creating a pipeline of product candidates to treat autoimmune disease and cancer.
Business Model:
Revenue: $0
Employees: 51-500
Trubion Pharmaceuticals was acquired by
Emergent BioSolutions.
The acquisition happend on 2010-08-12.
Details of the transaction were not public
Address:
City: Seattle
State: Washington
Zip:
Country: United States
Trubion Pharmaceuticals is a biopharmaceutical company creating a pipeline of product candidates to treat autoimmune disease and cancer. Our product candidates are novel proteins known as single-chain polypeptides and are designed using our SMIPTM custom drug assembly technology.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
10/18/2006
IPO Valuation:
$219M
Ticker Symbol:
TRBN
IPO Price:
$13/share
Amount Raised:
$52M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2002 | Series A | $13.6M | 9/2009 | Post-IPO Equity | $10M | 7/2004 | Series B | 6 | $32M |
ARCH Venture Partners Frazier Healthcare Partners Oxford Bioscience Partners Prospect Venture Partners Relay Ventures Venrock ARCH Venture Partners Frazier Healthcare Partners Oxford Bioscience Partners Prospect Venture Partners Relay Ventures Venrock |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|